Executive Vice President & CMO of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), Schwabe Stefan K.F., sells 46,347 shares worth $1,024,463

According to Supernus Pharmaceuticals, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 22 05:49 PM, company Executive Vice President & CMO, Schwabe Stefan K.F. disclosed selling 46,347 shares at a cost of $22.10. At the time of this transaction (Dec 21), this trade was worth $1,024,463 in total. As of Dec 21, Schwabe Stefan K.F. now owns 2,772 shares in total worth about $62,425.44.

For the last few recent trades made by Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Executive Vice President & CMO, Schwabe Stefan K.F., we have the following information:

  1. SEC Form 4 filing: Dec 14: Sold 53,653 shares at the rate of $21.87 per share. Total worth of this trade was $1,173,264. Total number of shares owned as of Dec 14 were 2,772
  2. SEC Form 4 filing: Jun 18: Sold 60,000 shares at the rate of $54.39 per share. Total worth of this trade was $3,263,352. Total number of shares owned as of Jun 18 were 1,967
  3. SEC Form 4 filing: Sep 07: Sold 95,000 shares at the rate of $46.59 per share. Total worth of this trade was $4,425,575. Total number of shares owned as of Sep 07 were 1,855
Posted by on Wednesday December 23 2020, 8:13 AM EST. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

Featured Press Releases

Log in